Liver cirrhosis bleeding: which procedure wins?
NCT ID NCT07490405
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two procedures for people with liver cirrhosis who have severe bleeding from enlarged veins in the esophagus and an enlarged spleen. One procedure removes the spleen and disconnects certain veins (LSD), while the other places a shunt inside the liver (TIPS). The main goal is to see which procedure causes fewer brain complications. The trial will follow 140 participants for long-term outcomes like survival and re-bleeding.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
laparoscopic splenectomy and azygoportal disconnection (LSD) or transjugular intrahepatic portosystemic shunt (TIPS)
What this could lead to
If this trial succeeds, it could show which procedure is safer and more effective for controlling bleeding and preventing brain complications in people with liver cirrhosis.
What could go wrong
This is a single-center trial with only 140 participants, so results may not apply to everyone. Both procedures carry risks like infection, bleeding, or liver problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Northern Jiangsu People's Hospital
Yangzhou, Jiangsu, 225000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••